U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development
PHOTO
U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit.
($1 = 0.9286 euros)
(Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
